Brain imaging software developer CorTechs Labs has received the CE Mark to distribute its NeuroQuant application in Europe.
The volumetric brain imaging software is designed to provide data analysis and detection of atrophy with automated MRI postprocessing capabilities, CorTechs said. NeuroQuant was previously cleared by the U.S. Food and Drug Administration (FDA).
NeuroQuant can help neurologists, radiologists, and clinical researchers quantify the volumes of specific brain structures for conditions such as Alzheimer's disease, traumatic brain injury, multiple sclerosis, and epilepsy, according to the company.
